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osting by EAbstract The present study was carried out to assess the predictive value and expression of the
proliferative activity of Ki-67 and the expression of p53 protein in Helicobacter pylori associated
chronic gastritis. This study comprised archival blocks from 20 dyspeptic patients who at National
Hepatology and Tropical Medicine Research Institute underwent a diagnostic oesophago-gastro-
duodenoscopy with multiple gastric antral endoscopic biopsies for histological examination. The
blocks were cut at 5 nM thicknesses, stained by hematoxylin and eosin to score the inﬂammatory
grade and subjected to Giemsa stain to assess H. pylori infection, and then immune–histochemical
method was done to determine protein P53 and Ki-67. The obtained results indicated that there was
no signiﬁcant association between the expression of Ki67 and P53 in the studied cases. There was no
signiﬁcant association between Ki67 and P53 in the presence of intestinal atrophy, intestinal meta-
plasia, intestinal activity and intestinal inﬂammation. While, there was signiﬁcant association
between Ki67 and P53 in intestinal dysplasia, P= 0.015, 0.025, respectively. It could be concluded
that the signiﬁcant association of the proliferative marker Ki-67 and apoptotic marker p53 protein
with intestinal dysplasia may be one of the main predictive values in the development of gastric car-
cinoma in patients with gastritis secondary to H. pylori infection.
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lsevier1. Introduction
Helicobacter pylori (HP) infection is one of the most common
chronic infections worldwide. Half of the global population is
infected by HP [6]. Chronic inﬂammation with H. pylori infec-
tion leads to mucosal atrophy and intestinal metaplasia, condi-
tions that are believed to be precursors of gastric cancer [6,12].
The development of gastric cancer has been shown to be a
multi step process, ranging from chronic gastritis to atrophy,
intestinal metaplasia, dysplasia and ﬁnally gastric cancer [9].
Both gastric atrophy and intestinal metaplasia are considered
Figure 1 Descriptive data of the studied cases.
Figure 2 There is no signiﬁcant association between expression
of Ki67 and P53 in the studied cases.
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nization establishes sustained insult to the gastric mucosa, and
hyper-proliferation of gastric epithelium in response to injury.
This in turn increases the risk of DNA damage (mutations),
epigenetic and morphological changes (intestinal metaplasia,
dysplasia), loss of responsiveness to apoptotic signals and, pre-
sumably, emergence of a clone of malignant cells that develop
into gastric cancer [7]. Expression of p53 protein is an early
event in tumorigenesis as observed in minute intramucosal gas-
tric adenocarcinoma [9,1]. P53 is an important prognostic fac-
tor in early gastric carcinoma [4].
Increased epithelial cell proliferation has also been ob-
served in H. pylori-associated gastritis, atrophic gastritis, and
gastric cancer [5]. Imbalance in epithelial cell proliferation
and apoptosis may be involved during the early stages of
malignant transformation [8]. The expression of the human
Ki-67 protein is strictly associated with cell proliferation.
Because the Ki-67 protein is present during all active phases
of the cell cycle, but is absent from resting cells, it makes an
excellent marker for cell proliferation [13,6].
The aim of study was to investigate the mucosal expression
of mutant p53 protein in association with proliferative (Ki-67)Figure 3 There is no signiﬁcant association between Ki67 and P
approaching signiﬁcance with intestinal inﬂammation (P= 0.065).markers in patients with atrophic gastritis secondary to
H. pylori infection.2. Material and methods
At the Gastrointestinal clinic in the National Hepatology and
Tropical Medicine Research Institute, the twenty dyspeptic
patients were subjected to full history taking including gastro-
intestinal symptoms and both general and local abdominal
examination and upper oesophago-gastroduodenoscopy
(GOD) and multiple antral biopsies (after stopping any Proton
Pump Inhibitor and antibiotics for at least 4 weeks) as well as
full routine labs.
Gastric antral biopsies were pathologically assessed in 20
dyspeptic patients with helicobacter infection. Epithelial prolif-
erative activity (Ki-67) and p53-expression were examined
quantitatively with cell counting after immunohistochemical
staining.3. Statistical methods
Categorical variables were expressed by number and percent.
Absence or presence of expression of P53 and/or Ki67 was as-
sessed with or without histopathological changes in the studied
patients using Chi-square test or Fischer’s exact test when
appropriate. Kendal–tau c values were calculated to assess
such ordinal association. In all tests, P value was considered
signiﬁcant if less than 0.05.4. Results
Patients mean age was 53 ± 5.1 with male to female ratio
1.75:1. Biopsies from 20 patients with H. pylori infection were
included in the study. Inﬂammatory gastritis, intestinal activ-
ity, intestinal metaplasia, atrophy and dysplasia were diag-
nosed in 20%, 14%, 8%, 10% and 6%, respectively. There
was no signiﬁcant association between the expression of
Ki67 and P53 in the studied cases. There was no signiﬁcant as-
sociation between Ki67 and P53 with intestinal atrophy, intest-
inal metaplasia, intestinal activity and intestinal inﬂammation.
There was signiﬁcant association between Ki67 and P53 with
intestinal dysplasia, P= 0.015, 0.025, respectively. Ki67 and
P53 were not age or sex dependent (Figs. 1–9).53 with intestinal inﬂammation. Though expression of P53 is
Figure 4 There is no signiﬁcant association between Ki67 and P53 with intestinal activity.
Figure 5 There is no signiﬁcant association between Ki67 and P53 with intestinal metaplasia. Though expression of Ki67 is approaching
signiﬁcance with intestinal metaplasia (P= 0.074).
Figure 6 There is signiﬁcant association between Ki67 and P53 with intestinal dysplasia. P= 0.015, 0.025, respectively.
Figure 7 There is no signiﬁcant association between Ki67 and P53 with intestinal atrophy.
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Figure 8 Showing a case of chronic gastritis, some glands on the
right show positive stain for P53 (100·).
Figure 9 Showing a case of chronic gastritis with positive
staining for Ki 67 (100·).
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In our study the patients’ mean age was 53 ± 5.1 with male to
female ratio 1.75:1, Mbulaiteye et al. [7] reported in his study a
range of age 55–81 years and male to female ratio 5:6.
Inﬂammatory gastritis, intestinal activity, intestinal meta-
plasia, atrophy and dysplasia were diagnosed in 20%, 14%,
8%, 10% and 6%, respectively. Mbulaiteye et al. [7] claimed
that infection rates peak at 80–100% during adolescence,
and may persist throughout life, particularly in less developed
countries. By contrast, in developed countries infection is ac-
quired later in childhood or adolescence, is cleared in about
10% of cases, and peaks at 50–70% during young adulthood.
There was no signiﬁcant association between P53 and Ki67
in presence of atrophy (P= 0.01) or metaplasia. This is in
accordance with Niimi et al. [9] and Waluga et al. [11] who
hypothesized that over expression of p53, and Ki-67 is not
speciﬁc neither for mucosal atrophy nor metaplasia. On the
contrary, Kim et al. [6] reported that Ki-67 was signiﬁcantlycorrelated with intestinal inﬂammation, intestinal metaplasia
and atrophy.
There was signiﬁcant association between Ki67 and P53 in
presence of intestinal dysplasia this coincides with the ﬁndings
of Choi et al. [3] who found that the high expressions of Ki-67
and p53 in gastritis may be one of the main mechanisms in the
development of gastric carcinoma. Brajsa et al. [2] hypothe-
sized that long persisting infection is related with higher
colonization grades of bacteria, p53 and Ki-67 expression.
6. Conclusion
The high expressions of the proliferative marker Ki-67 and
apoptotic marker p53 protein in gastritis may be one of the
main mechanisms in the development of gastric carcinoma.
References
[1] A.R. Andre´, M.V. Ferreira, R.M. Mota, A.C. Ferrasi, M.I.
Pardini, S.H. Rabenhorst, Cancer Epidemiol. 34 (5) (2010) 618–
625.
[2] K. Brajsa, Z. Ferencic, M. Katicic, S. Radosevic, V. Presecki, R.
Spaventi, M. Dominis, Hepatogastroenterology 53 (72) (2006)
968–972.
[3] S.C. Choi, Y.S. Kim, K.H. Kim, H.S. Kim, K.J. Yun, Korean J.
Neurogastroenterol. Motil. 13 (2) (2007) 118–122.
[4] A. Karaman, I. Pirim, Internet J. Genomic. Proteomic. 3 (1)
(2007).
[5] S.S. Kim, V.E. Ruiz, J.D. Carroll, S.F. Moss, Cancer Lett. 305
(2) (2011) 228–238.
[6] Kyung Mo Kim, Young Lyun Oh, Jae Sung Ko, Yon Ho Choe,
Jeong Kee Seo, J. Gastroenterol. 39 (2004) 231–237.
[7] S.M. Mbulaiteye, M. Hisada, E.M. El-Omar, Front. Biosci. 14
(2009) 1490–1504.
[8] A.N. Milne, G.J.A. Offerhaus, F. Carneiro, Histopathology of
familial and early-onset gastric cancer, Diagn. Histopathol. 17
(2) (2011) 62–68.
[9] C. Niimi, H. Goto, N. Ohmiya, Y. Niwa, T. Hayakawa, T.
Nagasaka, N. Nakashima, Am. J. Clin. Pathol. 118 (5) (2002)
683–692.
[10] F. Petersson, K. Borch, L.E. Franze´n, Dig. Dis. Sci. 47 (7)
(2002) 1558–1566.
[11] M. Waluga, M. Hartleb, P. Wandzel, A. Nowak, H. Bodys, T.
Roman´czyk, B. Matyszczyk, Prog. Med. Res. 2 (2004) 32.
[12] J. Wei, T.A. Nagy, A. Vilgelm, E. Zaika, S.R. Ogden, J.
Romero-Gallo, M.B. Piazuelo, P. Correa, M.K. Washington,
W. El-Rifai, R.M. Peek, A. Zaika, Gastroenterology 139 (4)
(2010) 1333–1343.
[13] H.H. Xia, G.S. Zhang, N.J. Talley, B.C. Wong, Y. Yang, C.
Henwood, J.M. Wyatt, S. Adams, K. Cheung, B. Xia, Y.Q. Zhu,
S.K. Lam, Am. J. Gastroenterol. 97 (12) (2002) 3023–3031.
